Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,088,600 | 3,261,300 | 1,934,700 | 1,011,100 | 4,347,700 |
| Depreciation Amortization | 1,462,200 | 1,117,600 | 747,900 | 385,900 | 1,373,600 |
| Income taxes - deferred | 126,000 | 206,200 | 150,700 | 132,100 | -268,500 |
| Accounts receivable | 361,800 | N/A | N/A | N/A | -188,800 |
| Accounts payable and accrued liabilities | -336,100 | N/A | N/A | N/A | 591,400 |
| Other Working Capital | -51,200 | -271,500 | -759,800 | -698,700 | 1,248,400 |
| Other Operating Activity | -346,500 | -610,800 | 85,000 | 22,100 | 130,700 |
| Operating Cash Flow | $5,304,800 | $3,702,800 | $2,158,500 | $852,500 | $7,234,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 375,100 | 257,300 | 608,700 | 457,600 | -250,900 |
| PPE Investments | -883,400 | -492,200 | -310,200 | -130,700 | -646,700 |
| Net Acquisitions | -199,300 | -199,300 | -199,300 | -195,400 | -307,800 |
| Purchase Of Investment | -7,618,600 | -5,341,800 | -3,476,600 | -2,156,100 | -4,624,400 |
| Sale Of Investment | 4,355,700 | 3,557,400 | 2,451,300 | 1,423,200 | 2,138,500 |
| Purchase Sale Intangibles | -138,800 | -102,000 | -67,900 | -33,600 | -632,900 |
| Other Investing Activity | 1,137,700 | 1,048,300 | -111,500 | -50,900 | -1,133,100 |
| Investing Cash Flow | $-2,832,800 | $-1,170,300 | $-1,037,600 | $-652,300 | $-4,824,400 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -6,700 | -6,700 | -5,300 | -134,100 |
| Debt Issued | N/A | -1,508,500 | -1,508,000 | -1,507,100 | N/A |
| Debt Repayment | -1,511,100 | N/A | N/A | N/A | -61,700 |
| Common Stock Repurchased | -721,100 | 0 | 0 | 0 | N/A |
| Dividend Paid | -2,187,400 | -1,639,200 | -1,095,000 | -544,600 | -2,180,100 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 6,000 |
| Financing Cash Flow | $-4,419,600 | $-3,154,400 | $-2,609,700 | $-2,057,000 | $-2,369,900 |
| Exchange Rate Effect | 43,900 | 18,600 | -87,900 | 56,500 | -110,900 |
| Beginning Cash Position | 5,922,500 | 5,922,500 | 5,922,500 | 5,922,500 | 5,993,200 |
| End Cash Position | 4,018,800 | 5,319,200 | 4,345,800 | 4,122,200 | 5,922,500 |
| Net Cash Flow | $-1,903,700 | $-603,300 | $-1,576,700 | $-1,800,300 | $-70,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,304,800 | 3,702,800 | 2,158,500 | 852,500 | 7,234,500 |
| Capital Expenditure | -905,400 | -492,200 | -310,200 | -130,700 | -672,000 |
| Free Cash Flow | 4,399,400 | 3,210,600 | 1,848,300 | 721,800 | 6,562,500 |